Tracking a targeted cancer therapy in Real-World patients

NCT ID NCT04727723

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is observing how well Lutathera works for adults with advanced neuroendocrine tumors of the gut or pancreas that have spread or cannot be removed by surgery. Researchers are following 164 patients who are already prescribed this treatment in standard care to see how long their cancer stays under control and how it affects their quality of life. The main goal is to measure how long patients live without their cancer getting worse after starting Lutathera.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Alessandria, Italy
Novartis Investigative Site

Bologna, Italy
Novartis Investigative Site

Brescia, Italy
Novartis Investigative Site

Cona, Italy
Novartis Investigative Site

Florence, Italy
Novartis Investigative Site

Latina, Italy
Novartis Investigative Site

Meldola, Italy
Novartis Investigative Site

Messina, Italy
Novartis Investigative Site

Milan, Italy
Novartis Investigative Site

Naples, Italy
Novartis Investigative Site

Negrar, Italy
Novartis Investigative Site

Padua, Italy
Novartis Investigative Site

Pisa, Italy
Novartis Investigative Site

Reggio Emilia, Italy
Novartis Investigative Site

Rionero in Volture, Italy
Novartis Investigative Site

Roma, Italy
Novartis Investigative Site

Rozzano, Italy
Novartis Investigative Site

Torino, Italy

Conditions

Explore the condition pages connected to this study.

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR